BackgroundCheck.run
Search For

Andrew C Good, 5834 Dexter Ave, Watertown, MA 02472

Related to:
Chad G Wagner 51 Laura A Good 51 John E Wagner 82

Andrew Good Phones & Addresses

34 Dexter Ave, Watertown, MA 02472   

Jamaica Plain, MA   

52 High Hill Rd, Wallingford, CT 06492    203-6790465   

Rocky Hill, CT   

San Francisco, CA   

52 High Hill Rd, Wallingford, CT 06492   

Work

Company: Good & cormier Address: 83 Atlantic Ave, Boston, MA 02110 Phones: 617-5235933 Position: Partner Industries: Legal Services

Education

Degree: Associate degree or higher

Ranks

Licence: Massachusetts - Active Date: 1972
Get Report
Control this profile

Mentions for Andrew C Good

Career records & work history

Lawyers & Attorneys

Andrew Good Photo 1

Andrew Good, Boston MA - Lawyer

Address:
Good Schneider Cormier
83 Atlantic Ave, Boston, MA 02110
617-5235933 (Office)
Licenses:
Massachusetts - Active 1972
Andrew Good Photo 2

Andrew Good, Boston MA - Lawyer

Address:
83 Atlantic Ave, Boston, MA 02110
Phone:
617-5235933 (Phone)
Experience:
52 years
Specialties:
Criminal Law
Jurisdiction:
Massachusetts (1972)
Memberships:
Massachusetts State Bar (1972)
Andrew Good Photo 3

Andrew Good - Lawyer

Specialties:
Insurance, Litigation, Military Law
ISLN:
923077400
Admitted:
2011
Law School:
Drexel University College of Law, JD - Juris Doctor, 2011

Andrew Good resumes & CV records

Resumes

Andrew Good Photo 51

Lawyer

Location:
Boston, MA
Industry:
Law Practice
Work:
Good & Cormier
lawyer
Andrew Good Photo 52

Andrew Good

Andrew Good Photo 53

Andrew Good

Andrew Good Photo 54

Andrew Good

Location:
United States

Publications & IP owners

Us Patents

Inhibitors Of Hepatitis C Virus

US Patent:
6867185, Mar 15, 2005
Filed:
Dec 12, 2002
Appl. No.:
10/317451
Inventors:
Jeffrey Allen Campbell - Cheshire CT, US
Andrew Charles Good - Wallingford CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K038/00
US Classification:
514 9
Abstract:
The present invention relates to macrocyclic compounds, methods for making these compounds, pharmaceutical compositions and the therapeutic or prophylactic use of these compounds by administering said compounds to mammals or treat hepatitis C virus (HCV) infection.

Heterocyclicsulfonamide Hepatitis C Virus Inhibitors

US Patent:
6869964, Mar 22, 2005
Filed:
May 20, 2003
Appl. No.:
10/441830
Inventors:
Jeffrey Allen Campbell - Cheshire CT, US
Andrew Charles Good - Wallingford CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D401/02
A61K031/47
US Classification:
514312, 546154
Abstract:
The present invention relates to tripeptide compounds, compositions containing such compounds and methods for using such compounds for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Hepatitis C Virus Inhibitors

US Patent:
6872805, Mar 29, 2005
Filed:
Nov 20, 2001
Appl. No.:
10/001850
Inventors:
Jeffrey Allen Campbell - Cheshire CT, US
Andrew Good - Wallingford CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K005/08
US Classification:
530331, 514 18, 514 19, 546134, 546153, 548535
Abstract:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Substituted Cycloalkyl P1′ Hepatitis C Virus Inhibitors

US Patent:
6878722, Apr 12, 2005
Filed:
May 20, 2003
Appl. No.:
10/441428
Inventors:
Jeffrey Allen Campbell - Cheshire CT, US
Stanley D'Andrea - Meriden CT, US
Andrew Good - Wallingford CT, US
Jianqing Li - Guilford CT, US
Fiona Mcphee - Wallingford CT, US
Amy Ripka - Cambridge MA, US
Paul Michael Scola - Glastonbury CT, US
Yong Tu - Cheshire CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D401/02
A61K031/47
US Classification:
514312, 546154
Abstract:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Hepatitis C Virus Inhibitors

US Patent:
6995174, Feb 7, 2006
Filed:
May 20, 2003
Appl. No.:
10/441657
Inventors:
Xiangdong Alan Wang - Guilford CT, US
Li-Qiang Sun - Glastonbury CT, US
Ny Sin - East Hampton CT, US
Paul Michael Scola - Glastonbury CT, US
Piyasena Hewawasam - Middletown CT, US
Andrew Charles Good - Wallingford CT, US
Yan Chen - Guilford CT, US
Jeffrey Allen Campbell - Cheshire CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 215/38
C07D 401/04
C07D 207/46
A61K 31/47
A61K 31/40
US Classification:
514312, 514313, 514314, 514343, 514423, 514422, 546159, 546160, 5462791, 546153, 548537
Abstract:
Hepatitis C virus inhibitors are disclosed having the general formula:.

Hepatitis C Virus Inhibitors

US Patent:
7041698, May 9, 2006
Filed:
May 20, 2003
Appl. No.:
10/441827
Inventors:
Amy Ripka - Branford CT, US
Jeffrey Allen Campbell - Cheshire CT, US
Andrew Charles Good - Wallingford CT, US
Paul Michael Scola - Glastonbury CT, US
Ny Sin - East Hampton CT, US
Brian Venables - Durham CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4015
C07D 207/04
US Classification:
514423, 548530, 548537, 514424
Abstract:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Macrocyclic Isoquinoline Peptide Inhibitors Of Hepatitis C Virus

US Patent:
7173004, Feb 6, 2007
Filed:
Apr 16, 2004
Appl. No.:
10/825693
Inventors:
Fiona McPhee - Wallingford CT, US
Jeffrey Allen Campbell - Glen Gardner NJ, US
Stanley D'Andrea - Meriden CT, US
Zhizhen Barbara Zheng - Cheshire CT, US
Andrew Charles Good - Wallingford CT, US
David J. Carini - Wallingford CT, US
Barry L. Johnson - Wallingford CT, US
Paul Michael Scola - Glastonbury CT, US
Kenneth M. Boy - Durham CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/00
US Classification:
514 10
Abstract:
Macrocyclic isoquinoline peptides are disclosed having the general formula:A compound of formula I:wherein Rto R, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

US Patent:
7309708, Dec 18, 2007
Filed:
Nov 18, 2004
Appl. No.:
10/992566
Inventors:
Yong Tu - Cheshire CT, US
Paul Michael Scola - Glastonbury CT, US
Andrew Charles Good - Wallingford CT, US
Jeffrey Allen Campbell - Glen Gardner NJ, US
Assignee:
Birstol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/47
C07D 217/00
US Classification:
514309, 514307, 546146, 546139, 546148, 546149
Abstract:
Hepatitis C virus inhibitors are disclosed having the general formula:.

Possible Relatives

Cynthia W Good  David A Good  Cyril Good  Debbie K Good  Dallas L Good  Debby Good  Deborah M Good  Andrew T Last  Andrew R Johnson  Andrew P Stanco 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.